Therapeutic efficacy of ofloxacin and ornidazole vs mebatic: Toxicity profile and antioxidant defense study

Research Journal of Parasitology

Volumn 4, Issue 3, 2009, Pages 79-86

  Soni, A ^a   Chaudhary, M ^a   Tamta, A ^a   Sehgal, R ^a   Shrivastava, S M ^a   Dwivedi, Vivek Kumar ^a  

^a Venus Medicine Research Centre   (India)

Author keywords

Antioxidant enzymes; Malonaldialdehyde; Mebatic; Ofloxacin; Ornidazole; Oxidative stress

Indexed keywords

ANTIBIOTIC AGENT; CATALASE; MEBATIC; OFLOXACIN; ORNIDAZOLE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; KIDNEY HOMOGENATE; LIVER HOMOGENATE; LIVER TOXICITY; MALE; MONOTHERAPY; MOUSE; NEPHROTOXICITY; NONHUMAN; OXIDATIVE STRESS; TOXICITY TESTING;

MUS;

EID: 72949092450     PISSN: 18164943     EISSN: None     Source Type: Journal    
DOI: 10.3923/jp.2009.79.86     Document Type: Article

References (24)

1. Bertino, J. and D. Fish, 2000. The safety profile of the fluoroquinolones. Clin. Ther., 22: 798-817.
2. Chowdhury, A., A. Santra, K. Bhattacharjee, S. Ghatak, D.R. Saha and G.K. Dhali, 2006. Mitochondrial oxidative stress and permeability transition in isoniazid and rifampicin induced liver injury in mice. J. Hepatol., 45: 117-126. (Pubitemid 43850617)
3. Clark, D.W., D. Layton, L.V. Wilton, G.L. Pearce and S.A. Shakir, 2001. Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: Experience from large cohorts from the drug safety research unit prescription-event monitoring database. Drug Saf., 24: 1143-1154.
4. Dharnidharka, V.R., K. Nadeau, C.L. Cannon, H.W. Harris and S. Rosen, 1998. Ciprofloxacin overdose: Acute renal failure with prominent apoptotic changes. Am. J. Kidney Dis., 31: 710-712.
5. Hamilton-Miller, J.M. and S. Shah, 1997. Activities of ciprofloxacin, levofloxacin, ofloxacin and sparfloxacin against speciated coagulase-negative staphylococci sensitive and resistant to fluoroquinolones. Int. J. Antimicrob. Agents, 9: 127-130.
6. Harputluoglu, M.M., U. Demirel, N. Karadag, D. Karahan, M. Aladag, M. Karincaoglu and F. Hilmioglu, 2007. Severe hepatitis with prolonged cholestasis and bile duct injury due the long-term use of ornidazole. Acta. Gastroenterol. Belg., 70: 293-295.
7. Khan, J.A., Z. Iqbal, S.U. Rahman, K. Farzana and A. Khan, 2008. Report: Prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics. Pak. J. Pharm. Sci., 21: 311-315.
8. Kumar, A., R.K. Kaundal, S. Iyer and S.S. Sharma, 2007a. Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sci., 80: 1236-1244. (Pubitemid 46329013)
9. Kumar, Y.S., S. Ramesh, Y.M. Rao and A.R. Paradkar, 2007b. Effect of rifampicin pretreatment on the transport across rat intestine and oral pharmacokinetics of ornidazole in healthy human volunteers. Drug Metabol. Drug Interact., 22: 151-163.
10. Kurt, O., N. Girginkardesler, I.C. Balcioglu, A. Ozbilgin and U.Z. Ok, 2008. A comparison of metronidazole and single-dose ornidazole for the treatment of dientamoebiasis. Clin. Microbiol. Infect., 14: 601-604.
11. Lomaestro, B.M., 2000. Fluoroquinolone-induced renal failure. Drug Saf., 22: 479-485.
12. Luck, H., 1957. Inactivation of catalase by hydrogen peroxide. J. Studies on the maximum amount of hydrogen peroxide cleavable by the enzyme. Biochemistry, 329: 165-174.
13. Messadi, A.A., T. Lamia, B. Kamel, O. Salima, M. Monia and B.R. Saida, 2008. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: A 5-year study, 2000-2004. Burns, 34: 1098-1102.
14. Michael, B., L. Hartmut, D. Karl-Matthias, G. Sabine and S. Fuat et al., 1990, Pharmacokinetics and serum bactericidal activities of quinolones in combination with clindamycin, metronidazole and ornidazole. Antimicrob. Agents Chemother., 34: 2407-2414.
15. Misra, H.P. and I. Fridovich, 1972. The role of superoxide anion in the auto-oxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 247: 3170-3175.
16. Montagnac, R., C. Briat, F. Schillinger, H. Sartelet, P. Birembaut and M. Daudon, 2005. Fluoroquinolone induced acute renal failure. General review about a case report with crystalluria due to ciprofloxacin. Nephrol. Ther., 1: 44-51.
17. Ohkawa, H., N. Ohishi and K. Yagi, 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem., 95: 351-358.
18. Paget, G.E. and J.M. Barnes, 1964. Evaluation of Drug Activities Pharmacometics. Academic Press, London and New York, pp: 1-135.
19. Pouzaud, F., M. Dutot, C. Martin, M. Debray, J.M. Warnet and P. Rat, 2006. Age-dependent effects on redox status, oxidative stress, mitochondrial activity and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 143: 232-241.
20. Ptitsina, S.N., V.I. Bobrov and M. M. Borisov, 2007. Chemotherapy activity and pharmacokinetics of the fluoroquinolones generics Ofloxacin-PhPO and Pefloxacin-genova. Antibiot. Khimioter., 52: 13-16.
21. Saracoglu, F., K. Gol, I. Sabin, B. Turkkani, C. Alalay and C. Oztopcu, 1998. Treatment of bacterial vaginosis with oral or vaginal ornidazole, secnidazole and metronidazole. Int. J. Gynaecol. Obstet., 62: 59-61.
22. Stratta, P., G.P. Segoloni, C. Canavese, G. Muzio and M. Dogliani et al., 1994. Oxygen free radicals are not the main factor in experimental gentamicin nephrotoxicity. Ren. Fail., 16: 445-455.
23. Tabak, F., R. Ozaras, Y. Erzin, A.F. Celik, G. Ozbay and H. Senturk, 2003. Ornidazole-induced liver damage: Report of three cases and review of the literature. Liver Int., 23: 351-354. (Pubitemid 37259205)
24. Tikoo, K., A. Tamta, I.Y. Ali, J. Gupta and A.B. Gaikwad, 2008. Tannic acid prevents azidothymidine (AZT) induced hepatotoxicity and genotoxicity along with change in expression of PARG and histone H3 acetylation. Toxicol. Lett., 177: 90-96.